GoHealth Files 8-K for September 30, 2024
Ticker: GOCO · Form: 8-K · Filed: Oct 1, 2024 · CIK: 1808220
| Field | Detail |
|---|---|
| Company | Gohealth, Inc. (GOCO) |
| Form Type | 8-K |
| Filed Date | Oct 1, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, regulation-fd, financials
Related Tickers: GOCO
TL;DR
GOCO filed an 8-K on 9/30, likely standard disclosures. Watch for details.
AI Summary
GoHealth, Inc. filed an 8-K on October 1, 2024, reporting events as of September 30, 2024. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits, with no specific material events detailed in the provided text.
Why It Matters
This 8-K filing indicates GoHealth, Inc. is providing updates or disclosures required by the SEC, which could contain material information for investors.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific material events or financial data that would indicate a high-risk situation.
Key Players & Entities
- GoHealth, Inc. (company) — Registrant
- 0001808220-24-000115 (filing_id) — Accession Number
- September 30, 2024 (date) — Date of earliest event reported
- October 1, 2024 (date) — Date of Report
- Chicago, Illinois (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for GoHealth, Inc.?
The primary purpose of this 8-K filing is to report on Regulation FD Disclosure and Financial Statements and Exhibits as of September 30, 2024.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted to the SEC on October 1, 2024.
What is GoHealth, Inc.'s principal executive office address?
GoHealth, Inc.'s principal executive offices are located at 222 W Merchandise Mart Plaza Suite 1750, Chicago, Illinois 60654.
What is GoHealth, Inc.'s telephone number?
GoHealth, Inc.'s telephone number is (312) 386-8200.
Under which section of the Securities Exchange Act is this report filed?
This report is filed as a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Filing Stats: 524 words · 2 min read · ~2 pages · Grade level 9.6 · Accepted 2024-10-01 08:35:06
Key Financial Figures
- $0.0001 — which registered Class A Common Stock, $0.0001 par value per share GOCO The Nasdaq Glo
Filing Documents
- goco-20240930.htm (8-K) — 24KB
- pressreleaseofgohealthin.htm (EX-99.1) — 10KB
- pressreleaseofgohealthin001.jpg (GRAPHIC) — 215KB
- pressreleaseofgohealthin002.jpg (GRAPHIC) — 212KB
- pressreleaseofgohealthin003.jpg (GRAPHIC) — 239KB
- pressreleaseofgohealthin004.jpg (GRAPHIC) — 30KB
- 0001808220-24-000115.txt ( ) — 1117KB
- goco-20240930.xsd (EX-101.SCH) — 2KB
- goco-20240930_lab.xml (EX-101.LAB) — 21KB
- goco-20240930_pre.xml (EX-101.PRE) — 12KB
- goco-20240930_htm.xml (XML) — 3KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On October 1, 2024, GoHealth, Inc. issued a press release announcing the closing of certain transactions with e-TeleQuote Insurance, Inc. A copy of the press release filed with this Current Report on Form 8-K is furnished as Exhibit 99.1 hereto and incorporated into this Item 7.01 by reference. The information in this Item 7.01 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, as amended (the "Exchange Act") or otherwise subject to liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such disclosure in this Current Report on Form 8-K in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. The following exhibits are included herewith: Exhibit Number Description 99.1 Press Release of GoHealth, Inc., dated October 1, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GOHEALTH, INC. Date: October 1, 2024 By: /s/ Brad Burd Brad Burd Chief Legal Officer